Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

188 questions in 27 reviews · Oral and maxillofacial surgery

current versions
No studies 188 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance
Patient quality of life · Adults aged 18 years or older with clinically diagnosed TMD (exhibiting two or more of the listed signs and/or symptoms) · At least 6 months after the intervention
Orthodontics for treating temporomandibular joint (TMJ) disorders (2010) · Cochrane
no estimate extracted0 studiesNo studies
Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance
Adverse effects on oral health · Adults aged 18 years or older with clinically diagnosed TMD (exhibiting two or more of the listed signs and/or symptoms) · At least 6 months after the intervention
Orthodontics for treating temporomandibular joint (TMJ) disorders (2010) · Cochrane
no estimate extracted0 studiesNo studies
Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance
Limitation of movement · Adults aged 18 years or older with clinically diagnosed TMD (exhibiting two or more of the listed signs and/or symptoms) · At least 6 months after the intervention
Orthodontics for treating temporomandibular joint (TMJ) disorders (2010) · Cochrane
no estimate extracted0 studiesNo studies
Open reduction and fixation vs Closed (conservative) management (no active intervention other than soft diet, analgesics or antibiotics; or intermaxillary/maxillary-mandibular fixation with rigid or elastic traction)
Outcome NR · Adults, over 18 years of age, with unilateral or bilateral fractures of the mandibular condyles
Interventions for the treatment of fractures of the mandibular condyle (2010) · Cochrane
no estimate extracted0 studiesNo studies
Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance
Development of TMD (onset/incidence of signs and symptoms) · People without TMD at baseline undergoing orthodontic treatment (TMD clinically absent at baseline); no age… · Follow-up period extended into adulthood
Orthodontics for treating temporomandibular joint (TMJ) disorders (2010) · Cochrane
no estimate extracted0 studiesNo studies
Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance
Overall symptoms, pain and headache (relief from symptoms assessed by global measures) · Adults aged 18 years or older with clinically diagnosed TMD (exhibiting two or more of the listed signs and/or symptoms) · At least 6 months after the intervention
Orthodontics for treating temporomandibular joint (TMJ) disorders (2010) · Cochrane
no estimate extracted0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Overall survival · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Quality of life (validated questionnaire) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned secondary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Disease-free survival · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Resectability · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Quality of life · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Postoperative swelling assessment · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · 0 to 48 hours after surgery
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned secondary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Degree of function postoperatively (mastication, swallowing, speech) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned primary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Adverse effects (insufficient fixation; re-operation/revision; plate exposure; superficial or deep wound infection; sinus tract; wound dehiscence; giant cell/foreign body or inflammatory reaction; post-traumatic dystrophy) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned adverse-effects outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved…0 studiesNo studies
Arthrocentesis and lavage vs Arthroscopy
Temporomandibular joint tenderness · Adults with temporomandibular joint disorders (internal derangement; anterior disc displacement with or without…
Arthrocentesis and lavage for treating temporomandibular joint disorders (2009) · Cochrane
To date, no randomised controlled trial in this area reported temporomandibular joint tenderness.0 studiesNo studies
Arthrocentesis and lavage vs Arthroscopy
Quality of life · Adults with temporomandibular joint disorders (internal derangement; anterior disc displacement with or without…
Arthrocentesis and lavage for treating temporomandibular joint disorders (2009) · Cochrane
No data about quality of life were reported by the included trials.0 studiesNo studies
Arthrocentesis and lavage vs Arthroscopy
Deviation of the mandible · Adults with temporomandibular joint disorders (internal derangement; anterior disc displacement with or without…
Arthrocentesis and lavage for treating temporomandibular joint disorders (2009) · Cochrane
To date, no randomised controlled trial in this area reported deviation of the mandible.0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Patient satisfaction (questionnaire) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned secondary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Arthrocentesis and lavage vs Arthroscopy
Muscular tenderness · Adults with temporomandibular joint disorders (internal derangement; anterior disc displacement with or without…
Arthrocentesis and lavage for treating temporomandibular joint disorders (2009) · Cochrane
To date, no randomised controlled trial in this area reported muscular tenderness.0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Direct costs (plates, supporting equipment, hospital bed days, retreatment) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned cost outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Analgesic medication used (type, dose, frequency) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned primary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Need for retreatment or replacement of fixation due to failure of the fixation · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned primary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Adverse events · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Any chronic or lasting pain measured using any validated scale after 3 weeks · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · After 3 weeks
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned primary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Arthrocentesis and lavage vs Arthroscopy
Maximum bite force · Adults with temporomandibular joint disorders (internal derangement; anterior disc displacement with or without…
Arthrocentesis and lavage for treating temporomandibular joint disorders (2009) · Cochrane
To date, no randomised controlled trial in this area reported maximum bite force.0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Complete remission · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Status of occlusion (e.g. Angle's classification, ANB, Wits analysis) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned secondary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Bioresorbable plates or screws (or both) vs Titanium plates or screws (used as lag screws) or both
Healing and union of fracture (versus mal-union and non-union) · Participants over 18 years of age with fractures of the facial skeleton including the mandible, maxilla, zygoma… · Up to 3 years postoperatively
Resorbable versus titanium plates for facial fractures (2009) · Cochrane
Planned primary outcome not assessed: none of the retrieved studies met the inclusion criteria, so no data were available for analysis. Verbatim (Effects of interventions): "Although 53 studies were retrieved in our…0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Partial reduction · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Primary surgical intervention (curettage, peripheral osteotomy, or resection) vs Primary non-surgical intervention (intralesional corticosteroids, subcutaneous calcitonin, interferon alpha, or imatinib)
Recurrence · Patients with a pathological diagnosis of central giant cell granuloma (CGCG) of the jaws
Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane
no estimate extracted0 studiesNo studies
Minimal incision palatopharyngoplasty (MIPP) vs MIPP with additional individualised velopharyngeal surgery (pharyngeal flap or sphincter pharyngoplasty)
Quality of life (self or carer evaluated, validated questionnaires) · Children or adolescents aged 3 years or older with velopharyngeal insufficiency (VPI) associated with non-syndromic…
Interventions for the management of submucous cleft palate (2008) · Cochrane
No data were available for this patient-reported outcome in the single included trial.0 studiesNo studies
Minimal incision palatopharyngoplasty (MIPP) vs MIPP with additional individualised velopharyngeal surgery (pharyngeal flap or sphincter pharyngoplasty)
Instrumental assessment: nasalance score (nasometry and pressure-flow measure) · Children or adolescents aged 3 years or older with velopharyngeal insufficiency (VPI) associated with non-syndromic…
Interventions for the management of submucous cleft palate (2008) · Cochrane
Nasalance score by nasometry and pressure-flow measure: the single included trial (Ysunza 2001) provided no data for this outcome.0 studiesNo studies
Minimal incision palatopharyngoplasty (MIPP) vs MIPP with additional individualised velopharyngeal surgery (pharyngeal flap or sphincter pharyngoplasty)
Self-esteem (validated questionnaires) · Children or adolescents aged 3 years or older with velopharyngeal insufficiency (VPI) associated with non-syndromic…
Interventions for the management of submucous cleft palate (2008) · Cochrane
No data were available for this patient-reported outcome in the single included trial.0 studiesNo studies
Minimal incision palatopharyngoplasty (MIPP) vs MIPP with additional individualised velopharyngeal surgery (pharyngeal flap or sphincter pharyngoplasty)
Adverse effect: unacceptable nasal resonance after repair · Children or adolescents aged 3 years or older with velopharyngeal insufficiency (VPI) associated with non-syndromic…
Interventions for the management of submucous cleft palate (2008) · Cochrane
The trial report provided no information on this adverse event; no information on adverse events or serious complications was reported.0 studiesNo studies
Occlusal adjustment (OA) vs Placebo
Psychosocial outcomes · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment for treating and preventing temporomandibular joint disorders (2003) · Cochrane
There were no data on psychosocial outcomes, costs or quality of life in any of the trials.0 studiesNo studies
Occlusal adjustment (OA) vs Placebo
Quality of life · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment for treating and preventing temporomandibular joint disorders (2003) · Cochrane
There were no data on psychosocial outcomes, costs or quality of life in any of the trials.0 studiesNo studies
Occlusal adjustment (OA) vs Placebo
Adverse events · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment for treating and preventing temporomandibular joint disorders (2003) · Cochrane
There were no reports of adverse reactions.0 studiesNo studies
Occlusal adjustment (OA) vs Placebo
Cost · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment for treating and preventing temporomandibular joint disorders (2003) · Cochrane
There were no data on psychosocial outcomes, costs or quality of life in any of the trials.0 studiesNo studies